News & Events

Featured News



The Israeli Supreme Court: Patent rights do not override Patients' rights!
  • The Israeli Supreme Court: Patent rights do not override Patients' rights!

    By Tal Band, Chair of the Intellectual Property practice group | 30/06/2016


    In a landmark judgment[1] rendered on June 15, 2016, the Supreme Court allowed an appeal filed by The Manufacturers Association of Israel (“the Association”), but denied that filed by Merck Sharp & Dohme Corp. (“MSD”), thereby determining that MSD's patent term extension (“PTE”) for ezetimibe (EZETROL®, marketed in the US under the name ZETIA®), has expired. The judgment has significant importance, both with respect to the constitutionality, as well as to the purposive interpretation of the amendment of the Israeli Patents Law, 1967 back in 2006.

    More

  • Our Firm successfully represented Haifa Port before the National Labor Court, in a lawsuit relating to management's ability to determine preconditions for employment. The case alleged that the Port's management cannot determine that one of the preconditions for the employment of a foreman is a certain grade on assessment tests. The court rejected the employee's argument and that these assessment tests are an integral part of the conditions for hiring personnel.

    More

  • The District Court has criticized the significant rise in class actions lawsuits filed against pharmaceutical companies In its decision in the recent Teva case, the Court stated that it will not accept applications to approve class action lawsuits that are lacking relevant medical reports, and will not enable plaintiffs to abuse their rights to appeal Learn more in the client update shared by our attorneys Hagai Doron and Dovev Apel in relation to this case, in which they represented Teva Pharmaceuticals Industries Ltd To read the full client update, please visit>> https://app.activetrail.com/S/eiwixt3xdtw.htm

    More
  • The Ministry of Health's new Hebrew website

    By S. Horowitz & Co. | 11/07/2017


    We would like to invite you to visit the Ministry of Health's new hebrew website, which aims to make accessible to the general public more information on clinical trials in Israel that use humans as subjects. Among many other issues, we explore this subject, the approval and supervision of clinical trial procedures, and the need for the hospital director's approval before these trials in our latest client update. To read the client update, please visit> https://app.activetrail.com/S/eiwixtzejj3.htm

    More
  • Are you prepared for the next cyber-attack?

    By S. Horowitz & Co. | 10/07/2017


    In his opinion column in financial newspaper Calcalist, attorney Amir Assali, partner in our Capital Markets department, advises public companies to examine their level of preparation for the cyber threats they face, and be fully transparent on that matter. To read the full piece in Calcalist, please visit>> http://www.calcalist.co.il/markets/articles/0,7340,L-3716603,00.html

    More

  • S. Horowitz & Co. has received the highest ranking in 2017 from five rating guides, placing the firm in the first tier. Year on year, the firm has consistently received widespread accolades through independent research and maintained its high position in international guides Legal 500, Chambers and Partners and IPStars, as well as domestic guides Duns 100 and BDI.

    More
  • A change in immediate reporting?

    By S. Horowitz & Co. | 14/06/2017


    The immediate reports filed by public companies to the Tel-Aviv Stock Exchange ("TASE") and to the Israel Securities Authority ("ISA") are a major component of the regulatory burden on companies listed for trade in Israel. A round table discussion took place with representatives from the ISA and TASE regarding the matter, where Amir Assali (a partner from the firm's Capital Markets department) participated and noted that "a few years ago, the ISA began promoting the "Project to Improve the Disclosure Requirements in Annual and Quarterly Reports" which is a welcomed initiative and in certain areas of activity, such as real estate, special disclosure requirements have been developed. I would be glad to see the continuation of this project since the proposed legislation in the matter has not been promoted since 2014." For the full article published in Ahad Ha'am Magazine (Hebrew), click here >> Https://cdn-media.web-view.net/i/dff3xp22as/__-____18-22.pdf#_atscid=4_75532_224605445_1997956_0_Txxewtfeejsswch2ww8

    More

  • The BDI 2017 guide ranked our firm in 32 practice areas, including 14 areas in the first tier: Litigation, Intellectual Property, Administrative Law, Energy and Infrastructure, Class Actions, Communication, Healthcare, Antitrust, International Commercial, Mergers & Acquisitions, Banking, Project Finance, Taxation and Higher Education.

    More

  • "This is a dramatic effect on the tax structures of many Israeli companies. Today, there is always a desire to transfer income to Israel or to countries with low tax rates. A change in the US tax rate will reverse the situation, encourage income retention in the US rates, and probably harm tax collection in Israel", said Leor Nouman, partner in S. Horowitz's Tax practice. In an interview with Globes, Leor discusses the implications of this major and far-reaching tax decision.

    More

  • S. Horowitz & Co. is delighted and proud to be ranked in the top tier in 10 practice areas, and ranked in a further 14 practice areas, according to the latest results just published by international legal directory Legal 500 2017. The 10 top tier rankings include Banking & Finance; Commercial, Corporate and M&A; Competition/Antitrust; Dispute Resolution - Class Actions; Dispute Resolution - Local Litigation and Arbitration; Infrastructure Projects; Intellectual Property – Disputes; Intellectual Property - Filing and Prosecution; Telecoms and Media and Transport - Other Transport. In addition, out of the 26 partners of our firm that are recommended in the guide's Israel chapter, eight are listed in the Elite category, including Alex Hertman and Yehoshua Horesh (Dispute Resolution - Local Litigation and Arbitration), Tal Band and Avi Ordo (Intellectual Property), Anthony Bloch (Banking & Finance); Clifford Davis (Commercial, Corporate and M&A); Hagai Doron (Competition/Antitrust); and Hugh Kowarsky (Transport - Other Transport). "Uncompromising professionalism" said Legal 500 about our firm.

    More

  • The well reputed IP rankings guide, IPStars, has recently published its 2017 IP rankings, positioning S. Horowitz as a tier 1 firm in both patent contentious and trademarks contentious. Our firm is one of two Israeli firms listed as top-tier in both categories and the only law firm amongst the 10 largest law firms in Israel that has been ranked in either tier 1 or 2. According to the publication "clients say the firm offers 'great service with efficiency and responsiveness'” and another client "commends S Horowitz & Co for 'great, efficient service and responsiveness'”.

    More